AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...
Managers of the top-performing, 96-year-old Vanguard Wellington Fund shared how they've crushed their competition in recent ...
Johnson & Johnson said Friday it would invest more than $55 billion in the U.S. in the next few years, adding to a series of investment commitments by big corporations. Here's a rundown of some of the ...
Market downturns are normal and offer opportunities to buy assets at discounted prices. See how to build wealth with ...
If 2025 is the year investment banking M&A makes a comeback, which banks will dominate deal-making in the market?
The Trump administration’s chaotic mix of tariffs and government budget cuts has jolted legions of everyday investors, ...
The ‘Oprah of Philanthropy’ is putting an undisclosed amount of her fortune into companies and funds that provide social and ...
The Vanguard Long-Term Corporate Bond ETF ( VCLT 0.79%) is currently the second-best option in the Vanguard family for ...
Gold's price is on the rise. Is it still worth it to invest in the precious metal? Here are the pros and cons.
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results